MRI tool may help young girls avoid unnecessary ovary removal
NCT ID NCT07313514
First seen Jan 08, 2026 · Last updated Jun 06, 2026 · Updated 26 times
Summary
This study looks at whether a special MRI scoring system called O-RADS can accurately predict if an ovarian mass in girls under 16 is cancerous or not. Researchers will review the MRI results of 100 girls who had surgery for ovarian masses. The goal is to help surgeons choose the right operation—removing just the mass or the whole ovary—to avoid spreading cancer while preserving healthy tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN; MASTOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service de Chirurgie Pédiatrique - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.